CHARACTERISTICS | BB-CAM USE | ||||
---|---|---|---|---|---|
Odds ratio | 95% CI | p | |||
Lower | Upper | ||||
Age (years) | |||||
≤60 yrs. | 1.00 (Reference) | ||||
>60 yrs. | .612 | .385 | .972 | .038 | |
Therapy | |||||
Bisphosphonates | No medication | 1.00 (Reference) | |||
Medication | .975 | .532 | 1.787 | .934 | |
Antibodies | No medication | 1.00 (Reference) | |||
Medication | .875 | .503 | 1.521 | .635 | |
Endocrine | No medication | 1.00 (Reference) | |||
Medication | 1.018 | .547 | 1.895 | .955 | |
Chemotherapy | No medication | 1.00 (Reference) | |||
Medication | 1.576 | .879 | 2.824 | .126 | |
Therapy line | .390 | ||||
Breast-Ca | Neoadjuvant | 1.00 (Reference) | |||
Adjuvant | .766 | .316 | 1.857 | ||
Metastasis 1st -line | .394 | .159 | .973 | ||
Metastasis 2nd -line | .823 | .302 | 2.242 | ||
Metastasis 3rd -line | 1.649 | .384 | 7.073 | ||
Metastasis ≥4th -line | .948 | .355 | 2.530 | ||
Recurrence 1st -line | .892 | .149 | 5.320 | ||
Recurrence ≥2nd -line | .372 | .054 | 2.544 | ||
Ovarian-Ca | Adjuvant | 1.072 | .371 | 3.099 | |
Recurrent | 1.035 | .363 | 2.955 |